Does Dr. OLUROTIMI ADEKOLU have financial conflicts of interest?

Dr. OLUROTIMI ADEKOLU (M.B.CH.B) has received a total of $10,618 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $10,618 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. OLUROTIMI ADEKOLU?

According to CMS Open Payments data, Dr. OLUROTIMI ADEKOLU received funding from GLAXOSMITHKLINE ($3,145), ASTRAZENECA PHARMACEUTICALS ($2,043), and HARMONY BIOSCIENCES ($839).

Does Dr. OLUROTIMI ADEKOLU receive research grants or speaking fees?

Dr. OLUROTIMI ADEKOLU has received $10,618 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. OLUROTIMI ADEKOLU

M.B.CH.BReal-Time Hydrated

Specialty: Internal Medicine, Pulmonary Disease

Practice Location: NEW HAVEN, CT 06510

NPI Number: 1073871372

LIFETIME INDUSTRY VALUE

$10,618

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ADEKOLU is a verified Internal Medicine, Pulmonary Disease practitioner based in NEW HAVEN, CT.

Between 2021 and 2024, Dr. ADEKOLU had an overall industry promotional and research financial footprint of $10,618 as recorded in the federal CMS Open Payments database.

$10,618 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADEKOLU's primary funding source is GLAXOSMITHKLINE, which accounts for $3,145 (representing 29.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$3,145

29.6%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$2,043

19.2%

HARMONY BIOSCIENCES

Rank 3

$839

7.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.